NCT ID

NCT05146336

Title

CytOSorb TreatMent Of Critically Ill PatientS Registry: International Registry on the Use of CytoSorb in the Critical Care Setting

Sponsor

CytoSorbents, Inc

Status

RECRUITING

Phase

Observational Registry

Condition raw

Septic Shock, Acute Respiratory Distress Syndrome, Trauma, Rhabdomyolysis, Cardiogenic Shock, Pancreatitis, Acute on Chronic Liver Failure, Acute Liver Failure, Burns, Chimeric Antigen Receptor T-Cell Therapy (CAR-T) Cytokine Release Syndrome (CRS), Extracorporeal Life Support, Postoperative Endocarditis, Hemophagocytic Lymphohistiocytoses, Liver Transplant; Complications, Infectious Disease, Postoperative Vasoplegic Syndrome, Drug Overdose, Sepsis

Condition normalized

Septic Shock, Acute Respiratory Distress Syndrome, Trauma, Rhabdomyolysis, Cardiogenic Shock, Pancreatitis, Acute on Chronic Liver Failure, Acute Liver Failure, Burns, Chimeric Antigen Receptor T-Cell Therapy (CAR-T) Cytokine Release Syndrome (CRS), Extracorporeal Life Support, Postoperative Endocarditis, Hemophagocytic Lymphohistiocytoses, Liver Transplant; Complications, Infectious Disease, Postoperative Vasoplegic Syndrome, Drug Overdose, Sepsis

Modality raw

medical device

Modality normalized

medical device

Target raw

CytoSorb device for hemoperfusion therapy targeting cytokine removal in critically ill patients.

Target normalized

CytoSorb device for hemoperfusion therapy targeting cytokine removal in critically ill patients.

Interventions

CytoSorb